Literature DB >> 1528007

Diseases resulting from mitochondrial DNA point mutations.

D C Wallace1, M T Lott, J M Shoffner, M D Brown.   

Abstract

A number of mitochondrial DNA (mtDNA) mutations have been identified which cause familial, late onset neuromuscular degenerative diseases. These include missense mutations in most of the mtDNA polypeptide genes as well as base substitutions in several tRNA genes. Missense mutations in the mitochondrial electron-transport genes cause Leber hereditary optic neuropathy. Ten mutations have been associated with this disease, but four at nps 11,178, 3460, 4160 and 15,257 appear sufficient in themselves to cause the disease. One missense mutation in the ATPase 6 gene at np 8993 causes a second phenotype, neurogenic muscle weakness, ataxia and retinitis pigmentosum. Transfer RNA mutations have been identified for myoclonic epilepsy and ragged-red fibre disease in the tRNA(Lys) gene at np 8344 and for the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome and for maternal mitochondrial myopathy and cardiomyopathy syndrome in the tRNA(Leu)(UUR) gene at nps 3234 and 3260, respectively. Deficiencies in mitochondrial oxidative phosphorylation enzymes have been observed in several common neurodegenerative diseases such as Alzheimer and Parkinson diseases. Perhaps mtDNA mutations play a role in these as well.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528007     DOI: 10.1007/bf01799605

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  40 in total

1.  Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  J F Hess; M A Parisi; J L Bennett; D A Clayton
Journal:  Nature       Date:  1991-05-16       Impact factor: 49.962

2.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

3.  Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease.

Authors:  D C Wallace; X X Zheng; M T Lott; J M Shoffner; J A Hodge; R I Kelley; C M Epstein; L C Hopkins
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

4.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

5.  Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.

Authors:  Y Tatuch; J Christodoulou; A Feigenbaum; J T Clarke; J Wherret; C Smith; N Rudd; R Petrova-Benedict; B H Robinson
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

6.  Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation.

Authors:  N Howell; I Kubacka; M Xu; D A McCullough
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

7.  Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR).

Authors:  M Zeviani; C Gellera; C Antozzi; M Rimoldi; L Morandi; F Villani; V Tiranti; S DiDonato
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

8.  Cytochrome oxidase deficiency in Alzheimer's disease.

Authors:  W D Parker; C M Filley; J K Parks
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

9.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  J M Shoffner; R L Watts; J L Juncos; A Torroni; D C Wallace
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

10.  Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease.

Authors:  M Corral-Debrinski; G Stepien; J M Shoffner; M T Lott; K Kanter; D C Wallace
Journal:  JAMA       Date:  1991-10-02       Impact factor: 56.272

View more
  11 in total

Review 1.  Mitochondrial genetic control of assembly and function of complex I in mammalian cells.

Authors:  A Chomyn
Journal:  J Bioenerg Biomembr       Date:  2001-06       Impact factor: 2.945

2.  The detection of mitochondrial DNA mutations using single stranded conformation polymorphism (SSCP) analysis and heteroduplex analysis.

Authors:  A W Thomas; R Morgan; M Sweeney; A Rees; J Alcolado
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

3.  Persistent impairment of mitochondrial and tissue redox status during lithium-pilocarpine-induced epileptogenesis.

Authors:  Simon Waldbaum; Li-Ping Liang; Manisha Patel
Journal:  J Neurochem       Date:  2010-10-26       Impact factor: 5.372

Review 4.  Mitochondrial-nuclear epistasis: implications for human aging and longevity.

Authors:  Gregory J Tranah
Journal:  Ageing Res Rev       Date:  2010-06-25       Impact factor: 10.895

5.  Mitochondrial DNA sequence variation is associated with free-living activity energy expenditure in the elderly.

Authors:  Gregory J Tranah; Ernest T Lam; Shana M Katzman; Michael A Nalls; Yiqiang Zhao; Daniel S Evans; Jennifer S Yokoyama; Ludmila Pawlikowska; Pui-Yan Kwok; Sean Mooney; Stephen Kritchevsky; Bret H Goodpaster; Anne B Newman; Tamara B Harris; Todd M Manini; Steven R Cummings
Journal:  Biochim Biophys Acta       Date:  2012-05-31

6.  Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness.

Authors:  S Manouvrier; A Rötig; G Hannebique; J D Gheerbrandt; G Royer-Legrain; A Munnich; M Parent; J P Grünfeld; C Largilliere; A Lombes
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

7.  Mitochondrial DNA damage and impaired base excision repair during epileptogenesis.

Authors:  Stuart G Jarrett; Li-Ping Liang; Jennifer L Hellier; Kevin J Staley; Manisha Patel
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

8.  Cytoplasmic transfer of the mtDNA nt 8993 T-->G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio.

Authors:  I Trounce; S Neill; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

9.  Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production.

Authors:  Corey M Harrison; Melissa Pompilius; Kent E Pinkerton; Scott W Ballinger
Journal:  Environ Health Perspect       Date:  2010-12-17       Impact factor: 9.031

10.  Increases in mitochondrial DNA content and 4977-bp deletion upon ATM/Chk2 checkpoint activation in HeLa cells.

Authors:  Rong Niu; Minoru Yoshida; Feng Ling
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.